Credit Suisse Initiates Coverage On Fulgent Genetics with Outperform Rating, Announces Price Target of $65
Credit Suisse analyst Dan Leonard initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Outperform rating and announces Price Target of $65.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 120 companies set new 52-week lows.
Recap: Fulgent Genetics Q2 Earnings
Fulgent Genetics (NASDAQ:FLGT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Fulgent Genetics beat estimated earnings by 6.85%, reporting an EPS of $0.78 versus an estimate of $0.73.
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell
• Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Earnings Outlook For Fulgent Genetics
Fulgent Genetics (NASDAQ:FLGT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement.
Analysts estimate that Fulgent Genetics will report an earnings per share (EPS) of $3.86.